Analyst Research: Acorda Therapeutics Inc (ACOR.OQ)

ACOR.OQ on NASDAQ Stock Exchange Global Select Market

37.26USD
1 Aug 2013
Price Change (% chg)

$-0.71 (-1.87%)
Prev Close
$37.97
Open
$37.97
Day's High
$38.40
Day's Low
$36.76
Volume
187,402
Avg. Vol
112,771
52-wk High
$40.87
52-wk Low
$21.34

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - ACORDA THERAPEUTICS, INC. (ACOR-O) 5:40am EDT Thomson Reuters Stock Report 12 25.00
ValuEngine Detailed Valuation Report for ACOR 31 Jul 2013 ValuEngine, Inc. 11 25.00
Wright Investors Service Comprehensive Report for Acorda Therapeutics, Inc. 31 Jul 2013 Wright Reports 41 472.00
Trading Report for (ACOR). A detailed report, including free correlated market analysis, and updates. 31 Jul 2013 Stock Traders Daily 5 58.00
The Investment Rate - a measure of investment demand. 29 Jul 2013 Stock Traders Daily 43 495.00
Acorda Therapeutics 27 Jul 2013 S&P Capital IQ Quantitative Report 5 58.00
ACORDA THERAPTUTICS INC (ACOR) 12-months forecast 26 Jul 2013 Pechala's Reports 1 15.00
Acorda Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 26 Jul 2013 Reuters Investment Profile 12 20.00
TheStreet.com Ratings Stock Report For: ACORDA THERAPEUTICS INC (ACOR) 20 Jul 2013 TheStreet.com Ratings 5 10.00
 
Name Age Since Current Position

Ronald Cohen

56 President,Chief Executive Officer, Director

David Lawrence

53 2005 Chief Financial Officer

Lauren Sabella

50 2010 Executive Vice President - Commercial Development

Andrew Blight

60 2004 Chief Scientific Officer

Jane Wasman

54 2012 President - International, General Counsel, Corporate Secretary
Search Stocks